Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Thoracic Cancer|May 21, 2025
Anlotinib Plus Osimertinib in Osimertinib-Resistant Nonsquamous Nonsmall Cell Lung Cancer With Gradual Progression: A Retrospective StudyYu Hua, Minghui Liu, Boshi Li, et al.
Clinical and Translational Medicine|January 4, 2025
Unravelling the prognostic and operative role of intratumoural microbiota in non-small cell lung cancer: Insights from 16S rRNA and RNA sequencingFuling Mao, Zixuan Hu, Ruifeng Shi, et al.
BMC Cancer|December 5, 2020
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cellsHao Gong, Yongwen Li, Yin Yuan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 22, 2019
[Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells]Hao Gong, Yin Yuan, Yongwen Li, et al.
Frontiers in Immunology|September 13, 2021
ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung CancerGuangsheng Zhu, Ruifeng Shi, Yongwen Li, et al.
Frontiers in Immunology|March 13, 2023
LINC01798/miR-17-5p axis regulates ITGA8 and causes changes in tumor microenvironment and stemness in lung adenocarcinomaXuanguang Li, Guangsheng Zhu, Yongwen Li, et al.
Translational Cancer Research|February 12, 2026
Integrative machine learning of hypoxia and centrosome-related gene signatures enables prognostic stratification and therapeutic insights in lung adenocarcinomaZexia Zhao, Hui Du, Chaoyi Jia, et al.
Journal of Cancer|August 18, 2021
HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancerWeiting Li, Yongwen Li, Hongbing Zhang, et al.
Journal of Cancer|April 5, 2024
ARID1B Deficiency Leads to Impaired DNA Damage Response and Activated cGAS-STING Pathway in Non-Small Cell Lung CancerGuangsheng Zhu, Jinghao Liu, Yongwen Li, et al.
Thoracic Cancer|November 22, 2021
Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysisYongwen Li, Ruifeng Shi, Guangsheng Zhu, et al.
Pageof 12